Rallybio Corp
RLYB
$16.86-0.35%
End of day · as of Sep 23, 2026, 9:21 PM ET
Mkt cap
$13.84M
EV/Sales
-20.43
P/E ratio
N/A
FY2025 Revenue
$858,000
EPS (H1 2026)
$6.16
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-1046.39%
Beta
-1.24
Div yield
N/A
Sector
Healthcare
Rallybio Corp (RLYB) is a biotechnology company listed on US.
Latest reported RLYB revenue for 2025-12-31 was $858.0K. Net income was -$9.0M. Revenue was up 43.0% from 2024-12-31 to 2025-12-31. RLYB currently screens at market cap $13.8M.
Use this RLYB research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RLYB income, balance, and cash tables.
Rallybio Corp (RLYB) is a biotechnology company in the Healthcare sector.
Latest cached Rallybio Corp (RLYB) revenue for Dec 31, 2025 was $858.0K. Net income was -$9.0M. Statements: https://lician.com/financials/rlyb
Rallybio Corp (RLYB) market capitalization is $13.8M on the latest cached snapshot.
Rallybio Corp (RLYB) cached previous close $16.92; day range $16.66 – $16.86; volume 5,334. Session quote: https://lician.com/quote/rlyb
Rallybio Corp (RLYB) latest cached earnings event is "RLYB earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached RLYB filing is 8-K · Sep 9, 2026. Filings: https://lician.com/sec/rlyb